22nd century stands ready to support the adoption of fda proposed tobacco product standard to mandate reduced nicotine content in cigarettes with its vln cigarettes

Fda reduced nicotine content proposal indicated to have completed omb review as of january 3, 2025 fda spokesperson indicates policy could be among most impactful population-level actions in the history of u.s. tobacco product regulation mocksville, n.c., jan. 13, 2025 (globe newswire) -- 22nd century group, inc. (nasdaq: xxii), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the u.s. food and drug administration's proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated to have cleared review by the u.s. office of management and budget on january 3, 2025.
XXII Ratings Summary
XXII Quant Ranking